| |
Company
Roster
|
|
Total
Insiders : |
21 |
|
|
|
Total
Direct Shares :
|
14,153,393 |
|
|
Total
Indirect Shares :
|
16,335,179 |
| |
%
Held by Insiders:
|
27.41% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Behbahani Ali |
|
2024-03-15 |
51,690 |
2024-03-15 |
4,448,757 |
| Dixon Wendy L |
|
2024-03-15 |
38,054 |
2022-06-17 |
0 |
| Bb Biotech Ag |
|
2023-10-17 |
8,517,839 |
|
0 |
| Velleca Mark A. |
|
2023-09-15 |
46,522 |
2022-03-18 |
0 |
| Epstein David M. |
|
2023-06-27 |
671,423 |
2023-06-27 |
265,146 |
| Jones Erika |
SEE REMARKS |
2023-02-13 |
10,150 |
2022-02-15 |
0 |
| Ingram Robert Alexander |
|
2022-12-16 |
42,854 |
2020-09-30 |
0 |
| Ni Fang |
|
2022-06-29 |
69,026 |
|
0 |
| Buck Elizabeth |
|
2021-09-15 |
95,192 |
|
0 |
| Shah Rajeev M. |
Director |
2021-05-20 |
0 |
2023-07-05 |
3,525,754 |
| Hatzis-Schoch Brent |
See Remarks |
2021-05-12 |
8,400 |
2020-02-03 |
0 |
| Roberts Christopher D. |
Chief Scientific Officer |
2021-05-03 |
3,200 |
2020-09-03 |
0 |
| Dhingra Kapil |
Director |
2021-01-19 |
10,000 |
|
0 |
| Leggett Thomas |
Chief Financial Officer |
2021-01-08 |
0 |
2020-09-14 |
0 |
| Bolzon Bradley J Phd |
Director, 10% Owner |
2020-12-14 |
21,851 |
2020-12-14 |
5,606,424 |
| Versant Vantage I, L.p. |
10% Owner |
2020-12-14 |
3,947,941 |
2020-12-14 |
1,658,483 |
| Humphrey Rachel |
Chief Medical Officer |
2020-09-08 |
10,000 |
2020-09-08 |
0 |
| Wellington Biomedical Innovation Master Investors |
10% Owner |
2020-02-03 |
568,185 |
2020-02-03 |
0 |
| Deerfield Partners, Lp |
Possible Member of 10% Group, 10% Owner |
2020-02-03 |
0 |
2020-02-03 |
778,790 |
| Mayweg Alexander |
Director |
2020-01-29 |
16,247 |
|
0 |
| Menzel Garry E |
Director |
2020-01-29 |
24,819 |
2020-02-03 |
51,825 |
|
|
0.78 (15.26%) 
